Advent Technologies Holdings Inc (ADN)

[KJAX]

New updates from ADN and acquired companies.
Also,
Advent has been issued, acquired, licensed, or applied for approximately 190 international and United States patents, with a concentration in membranes, electrodes, and MEAs, which support its product offerings. In the MEA sector, Advent’s products include two existing membrane technologies: “TPS®”, which Advent has exclusive rights to use and was obtained through patents filed by its founders and technical staff, and “PBI” technology, of which Advent is a selective licensee, and provides exclusive rights to Advent for commercial sale of MEAs using PBI technology. Leveraging its membrane technologies, Advent also has intellectual property for lightweight stacks made through advances in bipolar plate materials, which supports water-cooled systems. This results in a simpler and more compact balance-of-plant design. Advent’s own investments in developing leading next-generation fuel cell technology are supported by being able to leverage the research and development efforts of its strategic partners. Advent is planning next generation prototypes for fuel stacks as soon as 2021, with pilot production as soon as 2023 and mass production as soon as 2024.

https://sec.report/Document/0001140361-21-030988/brhc10028883_424b3.htm